diniprofylline manufacturers
- Diniprofylline
-
- $2500.00
-
2026-05-11
- CAS:17692-30-7
- Purity:
- Supply Ability: 10g
|
| | diniprofylline Basic information |
| Product Name: | diniprofylline | | Synonyms: | Bis(nicotinic acid)3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)propane-1,2-diyl ester;Bis(nicotinic acid)3-(2,3,6,7-tetrahydro-1,3-dimethyl-2,6-dioxo-1H-purin-7-yl)propane-1,2-diyl ester;BSM-5020M;Diniprophylline;diniprofylline;3-(1,3-Dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)propane-1,2-diyl dinicotinate;Coreverum;3-Pyridinecarboxylic acid, 1,1'-[1-[(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)methyl]-1,2-ethanediyl] ester | | CAS: | 17692-30-7 | | MF: | C22H20N6O6 | | MW: | 464.436 | | EINECS: | 2416821 | | Product Categories: | | | Mol File: | 17692-30-7.mol |  |
| | diniprofylline Chemical Properties |
| Boiling point | 735.5±70.0 °C(Predicted) | | density | 1.45±0.1 g/cm3(Predicted) | | pka | 3.02±0.10(Predicted) |
| | diniprofylline Usage And Synthesis |
| Uses | Diniprofylline, a bronchodilator, is a phosphodiesterase inhibitor. Diniprofylline possesses the potential to interact with human ACE2 and prevent its recognition by SARS-CoV-2[1]. | | References | [1] Kerem Teral, et al. Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment. J Mol Graph Model. 2020 Nov:100:107697. DOI:10.1016/j.jmgm.2020.107697 |
| | diniprofylline Preparation Products And Raw materials |
|